CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that its R&D Day presentation will be webcast live on the “Investors” section of the company’s website at www.alnylam.com.
